Delivery Order SPE2DB20D3103-SPE2DB25FP6D4
- Not listed
- The U.S. Defense Logistics Agency (DLA) has awarded a $6,022.62 Firm Fixed Price Delivery Order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,297,603 units of Epinephrine 1 mg/ml ampules. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Epinephrine 1 mg/ml ampules. This non-set-aside, competitively awarded contract is valued at $1,699.56 with a firm fixed price and an ultimate completion date of July 22, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency awarded a $6,265.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562304084 epinephrine 1 mg/ml ampules. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and calls for the delivery of the pharmaceutical products to a location in Conshohocken, Pennsylvania by September 27, 2023. As a major provider of medical supplies to the U.S. Department of Defense, this order supports the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $6,223.63 firm fixed-price delivery order is for the supply of Epinephrine 1mg/10mL, a medical product used in emergency situations. The contract has an ultimate completion date of August 4, 2025 and is not set aside for any specific business category. Amerisourcebergen Drug...
- This federal contract award is a delivery order valued at $1,190.67 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of epinephrine 1 mg/mL ampuls, a critical medication used for the treatment of severe allergic reactions. The contract is a firm fixed-price, non-set-aside arrangement with a performance period extending through April 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at one hundred twelve thousand two hundred twenty dollars to Amerisourcebergen Drug Corporation for the supply of epinephrine ampules. The firm fixed price order calls for the delivery of epinephrine to a facility in Conshohocken, Pennsylvania by August twenty-first, twenty twenty-three in support of DLA programs. Amerisourcebergen will serve as the prime contractor to provide the requested pharmaceutical products for the Agency, which...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the provision of Epinephrine Injection products. The order, valued at $1,033.92, has a completion date of July 20, 2023. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, with a potential value of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,443.97 firm fixed-price delivery order is for the procurement of epinephrine 1 mg/mL ampules to support military healthcare programs. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Epinephrine 0.3mg 2s. The contract is a Firm Fixed Price, non-set-aside award with a ceiling value of $45,683.70 and a period of performance through July 11, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that provides a comprehensive...
- The Department of Defense's Defense Logistics Agency awarded a firm-fixed-price delivery order to AmerisourceBergen Drug Corporation's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government. The $2,857.37 contract is for the delivery of Epinephrine 0.3 mg auto-injectors by September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025, which enables the DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6D4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $39,721.62 to AmerisourceBergen Drug Corp for the supply of Epinephrine 1 mg/mL ampules. This firm fixed-price, non-set-aside contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a critical pharmaceutical supply requirement for federal medical procurement, supporting military and veteran healthcare systems through DLA's medical supply chain operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a prime contractor on this comprehensive global pharmaceutical support vehicle, AmerisourceBergen Drug Corp supplies a broad spectrum of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's extensive portfolio of federal contract awards demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and healthcare systems, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $39.7k | 7/23/25 |